» Articles » PMID: 22367469

A Proposal for Combined MRI and PET/CT Interpretation Criteria for Preoperative Nodal Staging in Non-small-cell Lung Cancer

Overview
Journal Eur Radiol
Specialty Radiology
Date 2012 Feb 28
PMID 22367469
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine the positive reading criteria for malignant nodes when interpreting combined MRI and PET/CT images for preoperative nodal staging in non-small-cell lung cancer (NSCLC).

Methods: Forty-nine patients with biopsy-proven NSCLC underwent both PET/CT and thoracic MRI [diffusion weighted imaging (DWI)]. Each nodal station was evaluated for the presence of metastasis by applying either inclusive (positive if either one read positive) or exclusive (positive if both read positive) criteria in the combined interpretation of PET/CT and MRI. Nodal stage was confirmed pathologically. The combined diagnostic accuracy of PET/CT and MRI was determined on per-nodal station and per-patient bases and compared with that of PET/CT alone.

Results: In 49 patients, 39 (19%) of 206 nodal stations harboured malignant cells. Out of 206 nodal stations, 186 (90%) had concordant readings, while the rest (10%) had discordant readings. Inclusive criteria of combined PET/CT and MRI helped increase sensitivity for detecting nodal metastasis (69%) compared with PET/CT alone (46%; P = 0.003), while specificity was not significantly decreased.

Conclusion: Inclusive criteria in combined MRI and PET/CT readings help improve significantly the sensitivity for detecting nodal metastasis compared with PET/CT alone and may decrease unnecessary open thoracotomy. Key Points • Combined interpretation of MRI and PET/CT enhances the detection of nodal metastasis. • Inclusive criteria of combined MRI/PET/CT improved the sensitivity for detecting nodal metastasis. • Combined interpretation of MRI and PET/CT may reduce unnecessary open thoracotomies.

Citing Articles

Current status and prospect of PET-related imaging radiomics in lung cancer.

Tang X, Wu F, Chen X, Ye S, Ding Z Front Oncol. 2024; 13:1297674.

PMID: 38164195 PMC: 10757959. DOI: 10.3389/fonc.2023.1297674.


State of the Art MR Imaging for Lung Cancer TNM Stage Evaluation.

Ohno Y, Ozawa Y, Koyama H, Yoshikawa T, Takenaka D, Nagata H Cancers (Basel). 2023; 15(3).

PMID: 36765907 PMC: 9913625. DOI: 10.3390/cancers15030950.


Diagnostic value and clinical significance of MRI and CT in detecting lymph node metastasis of early cervical cancer.

Luo L, Luo Q, Tang L Oncol Lett. 2020; 19(1):700-706.

PMID: 31897185 PMC: 6924181. DOI: 10.3892/ol.2019.11180.


A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.

Pak K, Kim K, Kim M, Eom J, Lee M, Cho J PLoS One. 2018; 13(2):e0193403.

PMID: 29486012 PMC: 5828356. DOI: 10.1371/journal.pone.0193403.


Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.

Kim W, Lee S, Kim H, Chae Y, Jeong S, Jung J Sci Rep. 2018; 8(1):3181.

PMID: 29453385 PMC: 5816592. DOI: 10.1038/s41598-018-21554-z.


References
1.
Koh D, Collins D . Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007; 188(6):1622-35. DOI: 10.2214/AJR.06.1403. View

2.
Toloza E, Harpole L, McCrory D . Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003; 123(1 Suppl):137S-146S. DOI: 10.1378/chest.123.1_suppl.137s. View

3.
Rusch V, Asamura H, Watanabe H, Giroux D, Rami-Porta R, Goldstraw P . The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009; 4(5):568-77. DOI: 10.1097/JTO.0b013e3181a0d82e. View

4.
Nakayama J, Miyasaka K, Omatsu T, Onodera Y, Terae S, Matsuno Y . Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr. 2010; 34(1):1-8. DOI: 10.1097/RCT.0b013e3181a9cc07. View

5.
Gupta N, Graeber G, Bishop H . Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest. 2000; 117(3):773-8. DOI: 10.1378/chest.117.3.773. View